Non-opioid Pain Treatment Market Size Report, 2024 – 2032

Non-opioid Pain Treatment Market – By Drug Class (NSAIDs, Anesthetics, Antidepressants, Anticonvulsants), Medication Type, Indication (Neuropathic Pain, Post-Operative Pain), Route of Administration, Distribution Channel – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising geriatric population and concern for pain management

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing awareness of the risks associated with opioid use

3.2.1.3&nbsp;&nbsp;&nbsp; Expanding research funding and activities

3.2.1.4&nbsp;&nbsp;&nbsp; Growing advancements in the drug delivery system

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Side effects and safety concerns

3.2.2.2&nbsp;&nbsp;&nbsp; Availability of alternative therapies and non-pharmacological approaches

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Pipeline analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Drug Class, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Nonsteroidal anti-inflammatory drugs (NSAIDs)

5.3&nbsp;&nbsp;&nbsp; Local anesthetics

5.4&nbsp;&nbsp;&nbsp; Antidepressants

5.5&nbsp;&nbsp;&nbsp; Anticonvulsants

5.6&nbsp;&nbsp;&nbsp; Analgesics

5.7&nbsp;&nbsp;&nbsp; Other drug classes

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Medication Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Over-the-counter (OTC)

6.3&nbsp;&nbsp;&nbsp; Prescription

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Indication, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Neuropathic pain

7.3&nbsp;&nbsp;&nbsp; Post-operative pain

7.4&nbsp;&nbsp;&nbsp; Chronic back pain

7.5&nbsp;&nbsp;&nbsp; Cancer pain

7.6&nbsp;&nbsp;&nbsp; Migraine

7.7&nbsp;&nbsp;&nbsp; Arthritic pain

7.8&nbsp;&nbsp;&nbsp; Muscle sprain/strain

7.9&nbsp;&nbsp;&nbsp; Other indications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Route of Administration, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Oral

8.3&nbsp;&nbsp;&nbsp; Topical

8.4&nbsp;&nbsp;&nbsp; Injectable

8.5&nbsp;&nbsp;&nbsp; Other routes of administration

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

9.3&nbsp;&nbsp;&nbsp; Retail pharmacies

9.4&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Spain

10.3.5&nbsp;&nbsp;&nbsp;Italy

10.3.6&nbsp;&nbsp;&nbsp;Netherlands

10.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;Japan

10.4.2&nbsp;&nbsp;&nbsp;China

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.2&nbsp;&nbsp;&nbsp;South Africa

10.6.3&nbsp;&nbsp;&nbsp;UAE

10.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles 

11.1&nbsp;&nbsp;&nbsp; Amgen Inc.

11.2&nbsp;&nbsp;&nbsp; Almatica Pharma LLC

11.3&nbsp;&nbsp;&nbsp; Eli Lilly and Company

11.4&nbsp;&nbsp;&nbsp; Fresenius Kabi AG

11.5&nbsp;&nbsp;&nbsp; GlaxoSmithKline plc

11.6&nbsp;&nbsp;&nbsp; Haleon group

11.7&nbsp;&nbsp;&nbsp; Heron Therapeutics

11.8&nbsp;&nbsp;&nbsp; Hyloris Pharmaceuticals

11.9&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Consumer Inc.

11.10&nbsp;&nbsp;&nbsp; Neumentum Inc.

11.11&nbsp;&nbsp;&nbsp; Novartis AG

11.12&nbsp;&nbsp;&nbsp; Par Pharmaceutical, Inc.

11.13&nbsp;&nbsp;&nbsp; Pfizer Inc.

11.14&nbsp;&nbsp;&nbsp; Sanofi

11.15&nbsp;&nbsp;&nbsp; Scilex Holding Company

11.16&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries Ltd.

11.17&nbsp;&nbsp;&nbsp; Vertex Pharmaceuticals

11.18&nbsp;&nbsp;&nbsp; WEX Pharmaceuticals Inc.

&nbsp;&nbsp;&nbsp;

Nonopioid Pain Treatment Market

Get a free sample of this report